Royston Instruments Announces Acquisition of Controlling Stake in Biosan, Strengthening Global Life-Science and Laboratory Instrumentation Capabilities Royston, United Kingdom, 19th March 2026, Royston Instruments Ltd, a diversified technology group focused on advancing scientific instrumentation and data acquisition solutions, today announced that it has acquired a controlling stake in Biosan SIA, the Riga-based developer and manufacturer […]
Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be accretive to Agilent’s top-line growth rate, margin profile and non-instrument revenue mix in Year 1 SANTA CLARA, Calif. & SAN FRANCISCO, Calif. — Agilent Technologies Inc. (NYSE: A) today […]
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom. The total consideration was GBP 20.5 million, net of cash […]
SHENZHEN, China — MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, today announced the acquisition of STOmics and CycloneSEQ. It marks a significant milestone in MGI’s “SEQALL+GLI+Omics” strategy, positioning the company as the world’s only manufacturer of core life science tools spanning short-read […]
Divestiture streamlines operations and advances the Company’s strategy to fully exit non-core activities LOS ANGELES — Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces the sale of its ChromaDex Reference Standards business to LGC, as of February 24, 2026, in […]
The acquisition further enhances LGC’s ability to support pharmaceutical, food, and testing laboratories with trusted reference materials that underpin safety, quality, and regulatory confidence. London, UK — LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today announced the acquisition of the ChromaDex Reference Standards portfolio from Niagen Bioscience (NASDAQ: NAGE). The acquisition expands […]
SAN JOSE, Calif. and BASEL, Switzerland — Complete Genomics, a U.S.-based innovator in genomic sequencing technology, today confirmed that it has entered into a definitive agreement, subject to customary closing conditions and approval by MGI shareholders, under which it will be acquired by Swiss Rockets AG, a Switzerland-based life sciences group. The transaction will enable the scaling of the […]
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models Strengthens position as the leading independent provider of physiologically-relevant in vitro retinal models for ophthalmology drug discovery and safety testing Cambridge, UK and Newcastle, UK — Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug […]
Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials Sciences MILFORD, Mass. — Waters Corporation (NYSE: WAT) (“Waters”) today announced it has completed […]
Paris and Palo Alto – LBO France, a multi-specialist investment platform and pioneer in private equity, announced today the signing of a definitive agreement with Vivo Capital, a leading global investment firm focused exclusively on healthcare and life sciences, for the sale of Dutscher Group (‘Dutscher’ or ‘the Group’), the European leader in consumables and equipment distribution […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
